Association between cyclooxygenase-2-expressing macrophages, ulceration and microvessel density in colorectal cancer

Histopathology

Volumn 46, Issue 3, 2005, Pages 287-295

  Sheehan, Katherine M ^a   Steele, C ^a   Sheahan, K ^b   O'Grady, A ^a   Leader, M B ^a   Murray, F E ^a   Kay, E W ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Colon carcinoma; COX 2; Macrophage; Ulceration

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; CYCLOOXYGENASE 2;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; COLON ULCER; COLORECTAL CANCER; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM ULCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; ULCER HEALING;

ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MEMBRANE PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; ULCER;

EID: 14844318487     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02083.x     Document Type: Article

References (40)

1. Cancer in Ireland 1994-2000: incidence and mortality. Dublin: National Cancer Registry, 2002.
2. Thun MJ, Namboodiri MM, Health CW Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 1991: 325; 1593-1596.
3. Giardiello FM, Hamilton SR, Krush AJ et al. Treatment of colonic and rectal adenoma with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 1993: 328; 1313-1316.
4. Elder DJ, Halton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 selective NSAID. Clin. Cancer Res. 1997: 3; 1679-1683.
5. Shiff SJ, Qiao L, Tsai L, Rigas B. Sulindac sulfide, an aspirin like compound, inhibits proliferation, causes cell cycle quiescence and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 1995: 96; 491-503.
6. Kraemer SA, Meade SA, DeWitt DL. Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch. Biochem. Biophys. 1992: 293; 391-400.
7. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular and molecular biology. Annu. Rev. Biochem. 2000: 69; 145-182.
8. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and carcinomas. Gastroenterology 1994: 107; 1183-1188.
9. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998: 93; 705-716.
10. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl Acad. Sci. USA 1997: 94; 3336-3340.
11. Sheehan KM, Sheahan K, O'Donoghue DP et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 1999: 282; 1254-1257.
12. Masunaga R, Kohno H, Dhar DK et al. Cyclooxygenase-2 expression correlates with tumour neovascularization and prognosis in human colorectal cancer patients. Clin. Cancer Res. 2000: 6; 4064-4068.
13. Shiff SJ, Rigas B. NSAIDs and colorectal cancer: evolving concepts of their chemopreventative actions. Gastroenterology 1997: 113; 1992-1998.
14. Zeigler-Heitbrock HEL, Theil C, Haas JG, Moller A, Riethmuller G. Tumour necrosis factor in human monocyte-mediated anti tumour cytotoxicity. Net Immun. Cell Growth Regul. 1988: 7; 280-286.
15. Wu S, Boyer CM, Whitaker RS. Tumour necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumour cell proliferation and tumour necrosis factor alpha expression. Cancer Res. 1993: 53; 1939-1944.
16. Polverini PJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumour associated macrophages. Lab. Invest. 1984: 51; 635-642.
17. Huang ZF, Massey JB, Via DP. Differential regulation of cyclooxygenase-2 (COX-2) mRNA by interleukin-1 beta and tumour necrosis factor alpha in human in vitro differentiated macrophages. Biochem. Pharmacol. 2000: 59; 187-194.
18. Chapple KS, Cartwright EJ, Hawcroft G et al. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am. J. Pathol. 2000: 156; 545-553.
19. Chapple KS, Scott N, Guillou P, Coletta PL, Hull MA. Interstitial cell cyclooxyenase-2 expression is associated with increased angiogenesis in human sporadic adenomas. J. Pathol. 2002: 198; 435-441.
20. Fidler IJ, Ellis LS. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1984: 79; 185-188.
21. Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N. Correlation between vascular endothelial growth factor, angiogenesis and tumour-associated macrophages in invasive ductal breast carcinoma. Virchows Arch. 2002: 440; 583-588.
22. -/- mice. Gastroenterology 2000: 118; 337-345.
23. Δ716 mouse intestinal polyps. Cancer Res. 2002: 62; 506-511.
24. Masferrer JL, Isakson PC, Seibert K. Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. Gastroenterol. Clin. N. Am. 1996: 25; 363-372.
25. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 1993: 268; 9049-9054.
26. Wallace JL, Muscara MN. Selective cyclooxygenase-2 inhibitors: cardiovascular and gastrointestinal toxicity. Dig. Liver Dis. 2001: 33 (Suppl. 2); S21-28.
27. Lajoie S, Sirois J, Dore M. Induction of cyclooxygenase-2 expression in naturally occurring gastric ulcers. J. Histochem. Cytochem. 2002: 50; 923-934.
28. Araki H, Komoike Y, Matsumoto M, Tanaka A, Takeuchi K. Healing of duodenal ulcers is not impaired by indomethacin or rofecoxib, the selective COX-2 inhibitor, in rats. Digestion 2002: 66; 145-153.
29. Kato S, Ogawa Y, Kanatsu K et al. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant induced arthritis. J. Pharmacol. Exp. Ther. 2002: 303; 503-509.
30. Peskar BM, Maricic N, Gretzera B, Schuligoi R, Schmassmann A. Role of cyclooxygencise-2 in gastric mucosal defence. Life Sci. 2001: 69; 2993-3003.
31. Ma L, del Soldato P, Wallace JL. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: shifting the angiogenic balance. Proc. Natl Acad. Sci. USA 2002: 99; 13243-13247.
32. Guo JS, Cho CH, Liam Liu ES, Choy HT, Wang JY, Leung Koo MW. Antiangiogenic effect of a highly selective COX-2 inhibitor on gastric ulcer healing in rats. Toxicol. Appl. Pharmacol. 2002: 183; 41-45.
33. Cryer B. Mucosal defence and repair. Role of prostaglandins in the stomach and duodenum. Gastroenterol. Clin. N. Am. 2002: 30; 877-894.
34. Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest. 1996: 98; 2076-2085.
35. Bonner GF. Exacerbation of inflammatory bowel disease associated with use of Celecoxib. Am. J. Gastroenterol. 2001: 96; 1306-1308.
36. Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Suzuki M, Terao T. Thymidine phosphorylase expression in tumour-infitlrating macrophages may be correlated with poor prognosis in uterine endometrial cancer. Hum. Pathol. 2002: 33; 1105-1113.
37. Chen JJ, Yao PL, Yuan A et al. Up-regulation of tumour interleukin-8 expression by infiltrating macrophages: its correlation with tumour angiogenesis and patient survival in non-small cell lung cancer. Clin. Cancer Res. 2003: 9; 729-737.
38. Prall F, Gringmuth U, Nizze H, Barten M. Microvessel densities and microvessel arthictecture in colon carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival. Histapathology 2003: 42; 482-491.
39. Abdalla SA, Behzad F, Bsharah S et al. Prognostic relevance of microvessel density in colorectal tumours. Oncol. Rep. 1999: 6; 839-842.
40. Cianchi F, Cortesini C, Bechi P et al. Up-regulation of cyclooxygenase-2 gene expression correlates with tumour angiogenesis in human colon cancer. Gastroenterology 2001: 121; 1339-1347.